NUCLIONE UND RIBOCAPSIDE
European patent · EP2638160 · In force
Register entry
- Publication number
- EP2638160
- Application number
- EP11840569
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 7, 2011
- Published
- Sep 18, 2013
- Granted
- Jun 14, 2017
- Protection ends at the latest
- Nov 6, 2031
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C12N 15/11 (2006.01)C12Q 1/68 (2006.01)C12N 15/10 (2006.01)
- Priority
- US 411974 P 10.11.2010
- PCT application
- PCT/US2011/059656 07.11.2011
- PCT publication
- WO2012/064675 18.05.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 1, 2022
Change
Published in Swissreg on 01.12.2022
- Sep 23, 2021
Inventor
- Inventor
- GAMPER, Howard, B., Thomas Jefferson University, Department of Biochemistry and Molecular Biology, 233 South 10th Street, Philadelphia, PA 19107, USA → GAMPER, Howard, B., Thomas Jefferson University, Department of Biochemistry and Molecular Biology, 233 South 10th Street, Philadelphia, PA 19107, USA, WEBB, Nigel, L., 1101 Green Valley Road, Bryn Mawr, PA 19010, USA
Published in Swissreg on 23.09.2021
- Jun 14, 2017
Granted
Published in Swissreg on 14.06.2017
Parties
Inventor
GAMPER, Howard, B.
Philadelphia, PA 19107, US
WEBB, Nigel, L.
Bryn Mawr, PA 19010, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.